BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8217128)

  • 1. A comparison of bilateral and unilateral botulinum toxin treatments for spasmodic dysphonia.
    Zwirner P; Murry T; Woodson GE
    Eur Arch Otorhinolaryngol; 1993; 250(5):271-6. PubMed ID: 8217128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of botulinum toxin injection procedures in adductor spasmodic dysphonia.
    Adams SG; Hunt EJ; Irish JC; Charles DA; Lang AE; Durkin LC; Wong DL
    J Otolaryngol; 1995 Dec; 24(6):345-51. PubMed ID: 8699600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unilateral versus bilateral botulinum toxin injections in spasmodic dysphonia: acoustic and perceptual results.
    Adams SG; Hunt EJ; Charles DA; Lang AE
    J Otolaryngol; 1993 Jun; 22(3):171-5. PubMed ID: 8371328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of botulinum toxin type A injections on aerodynamic measures of spasmodic dysphonia.
    Adams SG; Durkin LC; Irish JC; Wong DL; Hunt EJ
    Laryngoscope; 1996 Mar; 106(3 Pt 1):296-300. PubMed ID: 8614192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unilateral versus bilateral thyroarytenoid Botulinum toxin injections in adductor spasmodic dysphonia: a prospective study.
    Upile T; Elmiyeh B; Jerjes W; Prasad V; Kafas P; Abiola J; Youl B; Epstein R; Hopper C; Sudhoff H; Rubin J
    Head Face Med; 2009 Oct; 5():20. PubMed ID: 19852852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the efficacy of unilateral versus bilateral botulinum toxin injections in the treatment of adductor spasmodic dysphonia.
    Maloney AP; Morrison MD
    J Otolaryngol; 1994 Jun; 23(3):160-4. PubMed ID: 8064952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of botulinum toxin therapy in patients with adductor spasmodic dysphonia: acoustic, aerodynamic, and videoendoscopic findings.
    Zwirner P; Murry T; Swenson M; Woodson GE
    Laryngoscope; 1992 Apr; 102(4):400-6. PubMed ID: 1556889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spasmodic dysphonia: botulinum toxin injection after recurrent nerve surgery.
    Ludlow CL; Naunton RF; Fujita M; Sedory SE
    Otolaryngol Head Neck Surg; 1990 Feb; 102(2):122-31. PubMed ID: 2113236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind controlled study of botulinum toxin in adductor spasmodic dysphonia.
    Troung DD; Rontal M; Rolnick M; Aronson AE; Mistura K
    Laryngoscope; 1991 Jun; 101(6 Pt 1):630-4. PubMed ID: 2041443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unilateral versus bilateral botulinum toxin injections in adductor spasmodic dysphonia.
    Langeveld TP; Drost HA; Baatenburg de Jong RJ
    Ann Otol Rhinol Laryngol; 1998 Apr; 107(4):280-4. PubMed ID: 9557760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adductor spasmodic dysphonia: case reports with acoustic analysis following botulinum toxin injection and acupuncture.
    Crevier-Buchman L; Laccourreye O; Papon JF; Nurit D; Brasnu D
    J Voice; 1997 Jun; 11(2):232-7. PubMed ID: 9181547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of spasmodic dysphonia with botulinum toxin].
    Klap P; Marion MH; Perrin A; Fresnel-Elbaz E
    Ann Otolaryngol Chir Cervicofac; 1991; 108(8):477-82; discussion 482-3. PubMed ID: 1789624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indirect laryngoscopic approach for injection of botulinum toxin in spasmodic dysphonia.
    Ford CN; Bless DM; Lowery JD
    Otolaryngol Head Neck Surg; 1990 Nov; 103(5 ( Pt 1)):752-8. PubMed ID: 2126097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective study of patients' subjective responses to botulinum toxin injection for spasmodic dysphonia.
    Liu TC; Irish JC; Adams SG; Durkin LC; Hunt EJ
    J Otolaryngol; 1996 Apr; 25(2):66-74. PubMed ID: 8683655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Indications for botulinum toxin in laryngectomy].
    Klap P; Marion MH; Perrin A; Fresnel-Elbaz E; Cohen M
    Rev Laryngol Otol Rhinol (Bord); 1993; 114(4):281-7. PubMed ID: 8029549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spasmodic dysphonia and laryngeal botulinum toxin injection.
    Smith ME
    West J Med; 1993 Jul; 159(1):74. PubMed ID: 8351914
    [No Abstract]   [Full Text] [Related]  

  • 17. The swallowing side effects of botulinum toxin type A injection in spasmodic dysphonia.
    Holzer SE; Ludlow CL
    Laryngoscope; 1996 Jan; 106(1 Pt 1):86-92. PubMed ID: 8544635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of botulinum toxin in the treatment of adductor spasmodic dysphonia.
    Whurr R; Lorch M; Fontana H; Brookes G; Lees A; Marsden CD
    J Neurol Neurosurg Psychiatry; 1993 May; 56(5):526-30. PubMed ID: 8505645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perceptual-acoustic relationships in spasmodic dysphonia.
    Zwirner P; Murry T; Woodson GE
    J Voice; 1993 Jun; 7(2):165-71. PubMed ID: 8353631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin injection of the vocal fold for spasmodic dysphonia. A preliminary report.
    Miller RH; Woodson GE; Jankovic J
    Arch Otolaryngol Head Neck Surg; 1987 Jun; 113(6):603-5. PubMed ID: 3566940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.